6. Multiplexed-PCR based next generation sequencing assay for diagnosis of bladder carcinoma in urine specimens

Background: Urine cytology has a low sensitivity for diagnosis of high grade urothelial carcinoma. Bladder cancer harbors frequent coding mutations in TP53, FGFR3, RAS, and PIK3CA, in addition to TERT promoter mutations. The study evaluates the feasibility of a multiplexed-PCR based Next Generation sequencing (NGS) assay on urine samples for diagnosis and monitoring of bladder carcinoma.
Source: Cancer Genetics and Cytogenetics - Category: Genetics & Stem Cells Authors: Source Type: research